Skip to content

Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries – Pfizer

Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries  PfizerPfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill  CNNPfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries  The New York TimesCovid-19 live updates: Pfizer deal would allow experimental covid-19 pill to be manufactured around the world  The Washington PostPfizer agrees to let other companies make its COVID-19 pill  Associated Press

Leave a Reply

Your email address will not be published. Required fields are marked *